These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2644924)

  • 21. [Cognitive impairment in multiple sclerosis].
    Niino M
    Rinsho Shinkeigaku; 2014; 54(12):1058-9. PubMed ID: 25519962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
    Korakas N; Tsolaki M
    Cogn Behav Neurol; 2016 Jun; 29(2):55-67. PubMed ID: 27336803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychological and neuropsychological problems in multiple sclerosis].
    Béquet D; Taillia H; Clervoy P; Renard JL; Flocard F
    Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis].
    Aldrete Cortez VR; Duriez-Sotelo E; Carrillo-Mora P; Pérez-Zuno JA
    Neurologia; 2013 Sep; 28(7):394-9. PubMed ID: 23260448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological aspects of childhood multiple sclerosis: an overview.
    Blaschek A; Storm van's Gravesande K; Heinen F; Pritsch M; Mall V; Calabrese P
    Neuropediatrics; 2012 Aug; 43(4):176-83. PubMed ID: 22605613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported executive dysfunction, neuropsychological impairment, and functional outcomes in multiple sclerosis.
    Basso MR; Shields IS; Lowery N; Ghormley C; Combs D; Arnett PA; Johnson J
    J Clin Exp Neuropsychol; 2008 Nov; 30(8):920-30. PubMed ID: 18608679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in patients with multiple sclerosis and mild physical disability.
    van den Burg W; van Zomeren AH; Minderhoud JM; Prange AJ; Meijer NS
    Arch Neurol; 1987 May; 44(5):494-501. PubMed ID: 2953326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
    Deloire M; Ruet A; Hamel D; Bonnet M; Brochet B
    Mult Scler; 2010 May; 16(5):581-7. PubMed ID: 20194578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating Neurocognitive Deficits in Patients With Multiple Sclerosis Via a Brief Neuropsychological Approach.
    Davis A; Williams RN; Gupta AS; Finch WH; Randolph C
    Appl Neuropsychol Adult; 2015; 22(5):381-7. PubMed ID: 25729879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety Levels Are Independently Associated With Cognitive Performance in an Australian Multiple Sclerosis Patient Cohort.
    Ribbons K; Lea R; Schofield PW; Lechner-Scott J
    J Neuropsychiatry Clin Neurosci; 2017; 29(2):128-134. PubMed ID: 27899051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognition is associated with gait variability in individuals with multiple sclerosis.
    Hsieh KL; Sun R; Sosnoff JJ
    J Neural Transm (Vienna); 2017 Dec; 124(12):1503-1508. PubMed ID: 29071439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three screening batteries to detect cognitive impairment in multiple sclerosis.
    Aupperle RL; Beatty WW; Shelton Fde N; Gontkovsky ST
    Mult Scler; 2002 Oct; 8(5):382-9. PubMed ID: 12356204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reduced metabolism in cerebral cortex correlates with MRI changes and cognitive dysfunction in patients with disseminated sclerosis].
    Blinkenberg M; Rune K; Jensen CV; Ravnborg MH; Kyllingsbaek S; Holm S; Paulson OB; Sørensen PS
    Ugeskr Laeger; 2001 Jul; 163(27):3788-92. PubMed ID: 11466987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients?
    Patti F; Di Stefano M; De Pascalis D; Ciancio MR; De Bernardis E; Nicoletti F; Reggio A
    Funct Neurol; 1995; 10(2):83-90. PubMed ID: 7557556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.